SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo
The presence of non-neutralizing antibodies of any dengue serotype increases the severity of subsequent infection by other dengue serotypes. During the SARS-CoV-2 pandemic, the number of symptomatic dengue cases increased in India. We found that antibo…